 |
인쇄하기
취소
|
KFDA approved second indication for Cozaar.
The KFDA approved Cozaar, an anti-hypertensive drug (Losartan K) of MSD Korea for the treatment of renopathy complicated with the type 2 diabetic patient as the 2nd indication.
The KFDA's approval was based on the study article titled "Reduction of Endpoints in NIDDM with the Angiotensin II antagonist Losartan" published by the New England Journal of Medicine in Sept. 2001.
The clinical s...
The KFDA's approval was based on the study article titled "Reduction of Endpoints in NIDDM with the Angiotensin II antagonist Losartan" published by the New England Journal of Medicine in Sept. 2001.
The clinical s...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.